Genetics Frontiers

Explore breakthrough studies and innovative genomic research

Research Articles

A Smarter Strike Against Blood Cancer: New Combo Therapy Shows Lasting Promise

New research shows Polatuzumab Vedotin combined with R-CHP offers promising results for Diffuse Large B-Cell Lymphoma patients with durable benefits.

Carter Jenkins
Oct 17, 2025

The Resistance Duo: How TP53 Mutations and MUSASHI-2 Help Lymphoma Evade Cutting-Edge Therapy

Discover how TP53 mutations and MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma and the promising combination strategies to overcome it.

Liam Carter
Aug 12, 2025

Popular Articles